Introduction Protection
Recently most sunscreens provide broad-spectrum UVprotection. Sun protection factor (SPF) implies the ability of UVB protection of sunscreens. For UVA, Japan Cosmetic Industrial Association proposed a labeling system of protection grade of UVA (PA) using immediate tanning as a measure 3) . The European Commission has also recommended the in vivo persistent pigment darkening (PPD) method 4) . In 2007, Food and Drug Administration has proposed a 4-star grading of UVA protection 5) . For appropriate use of sunscreens, correct knowledge of SPF and PA is needed.
Kawada et al. 6) studied the relationship between past history of sun exposure and photoaging signs. They investigated recent trends of sun exposure, freckles and wrinkles as photoaging symptoms, and skin phototype in a population of Japanese females. Then, they investigated the condition of sunscreen use and knowledge for SPF and PA in 2009. Five hundred and fourteen females, aged 20 to 69 years (mean 44 years), Japanese females, participated. They were given an online questionnaire consisting of multiple-choice and fill-in questions. By obtaining the history of each person's cutaneous response to first sun exposure, about 1 hr at the beginning of the summer, skin phototype was determined by the following Japanese skin type (JST) classification 4) : J-I burn easily and tan minimally; J-II 89 burn moderately and tan moderately; and J-III burn slightly and tan markedly. Subjects were classified into three skin phototypes: J-I, 161 (31%); J-II, 273 subjects (53%); and J-III, 80 (16%) subjects. Subjects who had had much, moderate, minimum, and little sun exposure were 23 (5%), 414 (80%), 63 (12%), and 14 (3%), respectively. A group with much and moderate sun exposure had remarkable freckles significantly more than a group with minimum and little sun exposure ( p < 0.01). Eighty-seven percent of all subjects knew the term of SPF, while only 14% of those (12% of all subjects) had an accurate understanding the definition of SPF ( Table 1) . This figure was similar to previous studies (10-13%) 7, 8) . Most subjects (84%) knew the term of PA, whereas only 9% of those (7% of all subjects) understood the correct meaning of PA ( Table 1) . Previous study in 2002 8) indicated that most subjects (93%) did not know the term of PA. These results suggested that education in the appropriate use of sunscreens and the meaning of SPF and PA is still needed. Dermatologists and manufacturers should make more efforts to give consumers more information about sunscreens.
fluences ranged from 20 to 24 J/cm 2 . Energy was delivered in double-or triple-pulse trains of 2.6-5.0 msec with pulse delays of 20 msec. Cutoff filters of 560 nm were used. Overall, 48% of subjects showed more than 50% improvement and 20% had more than 75% improvement. Only one case had erosions, and no other cases showed hyperpigmentation, scarring, or downtime. In the solar lentigines group, 40% of subjects showed more than 50% improvement and 16% had more than 75% improvement. IPL was effective for small plaques of solar lentigines, with 48% having more than 50% improvement. On the contrary, 72% of the patients with small + large and large plaques had poor or slight improvement. The solar lentigines + ephelides and ephelides groups showed great improvement, with 75% and 71%, respectively, having more than 50% improvement. Representative cases with marked response are shown in Fig. 1 and Fig. 2 . Therefore IPL may be added to the panel of modalities used for the treatment of ephelides and small-type solar lentigines.
Asian skin easily associates with hyperpigmentation after various therapies for photoaging skin, such as laser surgery 12, 13) , chemical peeling, and CO2 laser resurfacing. Q-switched ruby laser (QSRL) therapy, effective for solar lentigines in Japanese patients, causes postinflammatory hyperpigmentation, especially in patients with J-III 14) . QSRL therapy should be performed carefully because of hyperpigmentation in J-III subjects with more melanogenicity. However, IPL therapy in our study showed no postinflammatory pigmentation in any subjects including J-III patients, indicating that IPL may have an advantage over QSRL for the treatment of pigmentary disorders. Only one patient in our study showed burn from IPL. This patient's severe response may have been induced by ample amounts of melanin pigment in the lesion which is a target chromophore of IPL. Darker lesions and complexion should be treated cautiously because unexpected response may occur during IPL therapy. IPL therapy proved to be effective and tolerable for the patients, suggesting that IPL may be a possible good modality for solar lentigines and ephelides.
The mechanism of IPL therapy for solar lentigines
In order to reveal the mechanism of efficacy of intense pulsed light for solar lentigines, we performed histopathological examination 15) . Twenty patients (18 females and 2 males), ages 30 -78 years (mean 52 years), with solar lentigines participated in this study. Sequential histological pictures of small solar lentigines showed subepidermal cleft, vacuolization of pigmented basal keratinocytes and melanocytes, the disappearance of pigmentary incontinence in the papillary dermis at 30 m, lymphocytic infiltration in the upper dermis at 6 h, degenerated epidermis and enlargement of the cleft at 24 h, and crust at 7 days after irradiation (Fig. 3) . Results with Masson-Fontana staining also revealed vacuolated change of basal keratinocytes and melanocytes, degenerated epidermis with melanin pigments, and cr ust for mation containing ample melanins with decrease in melanin of basal cells. We demonstrated that clinical tiny-crust in the lesions of solar lentigines was the consequence of micro-crust formation histopathologically. Crust-formation was localized on the part of pigment spots, indicating the specificity of IPL for epidermal melanin under our condition. Formation and drop-off of the crusts lead to clinical improvement of pigmentary lesions of solar lentigines. Transient inf lammation with redness was seen, while no adverse sequelae such as hyperpigmenation and scarring appeared. Therefore, IPL may be a modality for solar lentigines as a highly selective therapy for pigment removal. 38 (24) 248 (91) (32 (12)) 25 (9) 199 (73) (17 (6)) 74 (27) 66 (82) (7 (9)) 14 (18) 56 (70) (4 (5))
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Therapy of photoaging
IPL, a broadband visible light emitted from a noncoherent, nonlaser, filtered f lashlamp, has been developed as a new noninvasive method 2, 9, 10) . IPL is effective for superficial rhytides, wrinkling, skin coarseness, irregular pigmentation, pore size, and telangiectases 2,9) .
IPL therapy for solar lentigines and ephelides
We performed an open study of IPL for the treatment of solar lentigines and ephelides 11) . Sixty patients (56 women, 4 men), age 20-82 years (mean 50 years), with facial pigmentary lesions participated in this study. Facial pigmentary lesions were clinically diagnosed as solar lentigines, solar lentigines + ephelides, and ephelides. Solar lentigines were also classified into small (1 cm and less than 1 cm) and large plaques (more than 1 cm). A noncoherent, f iltered, broadband, pulsed flashlamp (NatuLight, Lumenis CO., LTD. (Koto-ku, Tokyo Japan)) emitting in the range of 500-1200 nm was used for all treatments. Each patient received three to five treatments (average number 4.0), given at 2-to 3-week intervals. Treatment 
Novel IPL modality for solar lentigines and ephelides
Recently a novel IPL source (Lumenis One™, Lumenis CO., LTD.) with stronger irradiation and various filters has been developed as a second generation of IPL. Lumenis One is a phototherapy unit that composes of IPL, LightSheer diode laser for hair removal, and Multi-Spot Nd:YAG laser for leg veins and deeper vascular lesions. IPL of Lumenis One is characterized with stronger intensity, two spot sizes, replaceable seven filters, and an integrated dynamic cooling device, designating as a second platform of IPL. We investigated clinical effectiveness of Lumenis One on facial pigmentary lesions 16) . Eighteen Japanese female patients aged 22-72 years (mean 50 years), with facial pigmentary lesions (solar lentigines, solar lentigines + ephelides, and ephelides), participated in this study. Each patient received three to five treatments. Each treatment, given at 2-3-week intervals, was administered on the face. Treatment fluences ranged from 12 to 14 J/cm 2 . Energy was delivered in double pulse trains of 4.0 ms with pulsedelays of 20 ms. Cutoff fillters of 560 nm were used. All the patients completed the study. No adverse effectswere seen in any patients. Physicians' overall assessments demonstrated clinical improvement in the total population, indicating that 28% of patients showed marked improvement, none did moderate improvement, and 39% did slight improvement. Thirty-three percent showed no change, while no patients did "worsened". The melanin index decreased after the treatment comparing before the treatment. These results revealed the clinical effectiveness with well tolerability on facial pigmentary lesions, such as solar lentigines, ephelides, and solar lentigines + ephelides.
Conclusion
Photoaging skin is an important issue in the dermatological field. Various signs of photoaging include pigmentary lesions, wrinkles, changes of texture, benign tumors, and skin cancers. Daily sun protection is important to prevent these symptoms. Recent development of phototherapy helps improvement of pigmentary lesions.
